Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded

M A Vasef1, L J Medeiros, L S Yospur

  • 1Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.

Insights

Cyclin D1 protein is expressed in about 26% of plasma cell neoplasms, including multiple myeloma. This expression correlates with tumor differentiation and stage, suggesting mechanisms beyond the t(11;14) translocation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Plasma cell neoplasms are a group of hematologic malignancies.
  • Cyclin D1 is a cell cycle regulatory protein.
  • The t(11;14) translocation is a known genetic abnormality in some plasma cell neoplasms.

Purpose of the Study:

  • To investigate the expression of cyclin D1 protein in various plasma cell neoplasms.
  • To determine the correlation between cyclin D1 expression and clinicopathologic features.
  • To explore the relationship between cyclin D1 expression and the t(11;14) translocation.

Main Methods:

  • Immunohistochemistry was used to detect cyclin D1 protein in 69 plasma cell neoplasms (54 multiple myelomas, 3 plasma cell leukemias, 12 plasmacytomas).
  • Tissue sections were routinely fixed and paraffin-embedded.
  • Polymerase chain reaction (PCR) was used to analyze for the t(11;14) translocation in a subset of cases.

Main Results:

  • Cyclin D1 protein was expressed in 18 (26%) of 69 cases.
  • Expression was observed in 16 (30%) of multiple myelomas and 2 (17%) of plasmacytomas.
  • Cyclin D1 expression correlated with intermediate/immature cytologic features and histologic Stage III in multiple myeloma.
  • Only one multiple myeloma case harbored the t(11;14) translocation and expressed cyclin D1.

Conclusions:

  • Cyclin D1 protein expression is found in approximately one-quarter of plasma cell neoplasms.
  • Cyclin D1 expression is associated with specific cytologic and histologic characteristics of multiple myeloma.
  • The frequent cyclin D1 expression, relative to the incidence of t(11;14), suggests alternative regulatory mechanisms are involved.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...